Malignant biphasic mesothelioma

MONDO:0006109

A malignant neoplasm arising from mesothelial cells in the pleura. It is characterized by the presence of neoplastic epithelioid cells and sarcomatoid features.

Also known as: biphasic mesothelioma, malignant biphasic mesothelioma, malignant biphasic mesothelioma, malignant, malignant mixed mesothelioma, mesothelioma, biphasic, malignant (morphologic abnormality), mixed mesothelioma

2734 clinical trials for this condition and its sub-types, 2 tagged with Malignant biphasic mesothelioma itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Malignant mesothelioma (108)

Sub-types of Malignant biphasic mesothelioma

Pleural biphasic mesothelioma 4 trials

Including sub-types (2734) Tagged with Malignant biphasic mesothelioma (2)

Not yet finished but already full! 1 Completed 1

New drug cocktail aims to boost mesothelioma surgery success

Disease control Ongoing

This early-phase trial is testing whether adding the immunotherapy drug atezolizumab to standard chemotherapy (cisplatin and pemetrexed) before and after surgery can help people with resectable pleural mesothelioma. The study includes 28 participants with stage I-III disease. The…

Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Aug 06, 2026 00:00 UTC

Malignant biphasic mesothelioma

Where it sits in the disease tree

New drug cocktail aims to boost mesothelioma surgery success